Active ingredient: Levomycetin (Chloramphenicol) – 0.25 g;

Excipients: Boric acid, distilled water.
Description: Colorless, transparent liquid
Pharmacotherapeutic group: Antibiotics (chloramphenicol group)

Pharmacological action:
Levomycetin eye drops belong to the group of broad-spectrum antibiotics for topical use.
It has a bacteriostatic effect on Gram-positive and Gram-negative bacteria, including microorganisms resistant to penicillin, tetracycline antibiotics, and sulfonamides.
After instillation, the drug acts not only locally but also partially penetrates into the systemic circulation.

Indications for use:
Levomycetin is used for the treatment of inflammatory processes of bacterial origin localized in the cornea or conjunctiva (conjunctivitis, keratitis, keratoconjunctivitis, blepharitis);
Contraindications:

The drug is not used:
- In patients with impaired hematopoiesis;
- In patients with renal or hepatic insufficiency;
- In case of hypersensitivity to the components of the drug;

Levomycetin is used with caution during pregnancy and lactation, in newborns and children under 2 years of age, as well as in patients with skin diseases (eczema, psoriasis).

Method of administration and dosage: Instill 1 drop into the affected eye every 1–4 hours; after improvement of the condition, 1 drop every 4–6 hours.

Side effects:
In some cases, the drug may cause local irritation (burning, itching, redness of the eyes). With prolonged use (3 weeks or more) – adverse changes in the hematopoietic system (thrombocytopenia, leukopenia, aplastic anemia) may occur, and secondary fungal infections may develop. If the indicated symptoms appear, the drug should be discontinued and symptomatic treatment prescribed.


Special instructions and precautions:
- The risk of side effects when using Levomycetin eye drops increases when administered simultaneously with drugs that suppress hematopoiesis (cytostatics, sulfonamides), as well as during radiation therapy.
- Soft contact lenses should be removed before use.
- Contact lenses may be reinserted 30 minutes after instillation.
- If use of the drug causes blurred vision, refrain from activities requiring increased concentration and attention until vision is restored.

Storage conditions: Store protected from light at a temperature not exceeding 25°C. After opening the bottle, use within 1 month.
Shelf life:2 years.

Dispensing conditions: Pharmaceutical product group – II, dispensed with prescription form No. 3

Manufacturer:
LLC “Dentafill Plyus” (Dentafill Plyus)
100209, Republic of Uzbekistan, Tashkent, Sergeli district, Margib Street, Building #1.
Tel/Fax: (+998 71) 231-78-00 www.dentafill.uz